These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19281323)

  • 1. The HPV vaccine: a content analysis of online news stories.
    Habel MA; Liddon N; Stryker JE
    J Womens Health (Larchmt); 2009 Mar; 18(3):401-7. PubMed ID: 19281323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.
    Calloway C; Jorgensen CM; Saraiya M; Tsui J
    J Womens Health (Larchmt); 2006 Sep; 15(7):803-9. PubMed ID: 16999634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer?
    Kelly BJ; Leader AE; Mittermaier DJ; Hornik RC; Cappella JN
    Patient Educ Couns; 2009 Nov; 77(2):308-13. PubMed ID: 19395221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk messages about HPV, cervical cancer, and the HPV vaccine gardasil in North American news magazines.
    Abdelmutti N; Hoffman-Goetz L
    J Cancer Educ; 2010 Sep; 25(3):451-6. PubMed ID: 20232189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
    Brotherton JM; Kaldor JM; Garland SM
    Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles.
    Abdelmutti N; Hoffman-Goetz L
    Women Health; 2009; 49(5):422-40. PubMed ID: 19851946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
    Steele CB; Thomas CN; Richardson LC
    J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bug breakfast in the bulletin: human papilloma virus.
    Wallace C; Weisberg E; McCaffery K
    N S W Public Health Bull; 2007; 18(5-6):97-8. PubMed ID: 17907356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationships Between Social Media and Human Papillomavirus Awareness and Knowledge: Cross-sectional Study.
    Jo S; Pituch KA; Howe N
    JMIR Public Health Surveill; 2022 Sep; 8(9):e37274. PubMed ID: 36125858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):311-5. PubMed ID: 16866792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Cancer Patients' Willingness and Ability to Serve as Health Care Educators to Advocate for Human Papillomavirus Vaccine Uptake.
    Ladd IG; Gogoi RP; Bogaczyk TL; Larson SL
    J Cancer Educ; 2019 Jun; 34(3):608-613. PubMed ID: 29574539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali.
    Poole DN; Tracy JK; Levitz L; Rochas M; Sangare K; Yekta S; Tounkara K; Aboubacar B; Koita O; Lurie M; De Groot AS
    PLoS One; 2013; 8(2):e56402. PubMed ID: 23431375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic HPV vaccines.
    Szarewski A
    Eur J Gynaecol Oncol; 2007; 28(3):165-9. PubMed ID: 17624079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
    Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers.
    Gerend MA; Shepherd MA; Lustria ML
    Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV in men is a women's health issue.
    Fontenot HB; Morelock N
    Nurs Womens Health; 2012; 16(1):57-65. PubMed ID: 22900728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.